Synosia Therapeutics
UCB signs Parkinson’s research deal
October 12, 2010Research and Development Parkinson's, Synosia Therapeutics, UCB, neurology
UCB has partnered with Synosia Therapeutics to develop two of the Swiss firm’s compounds for Parkinson’s disease. Basel-based Synosia has …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
